Bangladeshi one-day and T-20 cricket captain Mashrafe Bin Mortaza urged people living with diabetes to start a good innings as early as possible for changing diabetes.
“If anyone wants to live well with diabetes, the best option is to be diagnosed and treat early to avoid long term complications,” Mashrafe said at press meet on ‘star early, change diabetes’.
The press meet was organised by Danish pharma giant Novo Nordisk, who is working for changing diabetes over 50 years in Bangladesh.
The captain will work to create awareness on the primary prevention, early diagnosis, better treatment and good control of diabetes. He will also focus on the benefit of healthy lifestyle and diet to prevent diabetes.
Mashrafe said: people living with diabetes should maintain 678 numbers to live well. He explained six as blood glucose level before breakfast, seven as HBA1C (three-month average blood glucose level) and eight as blood glucose level two hours after breakfast.
Peter Ulvskjold, Corporate Vice President, Business Area South East Asia, said, unfortunately, diagnosis in itself isn’t enough to reverse the global diabetes burden.
Out of the people who are diagnosed with diabetes, it is estimated that around 50 percent receive care – however, less than half of those who receive care achieve their treatment targets, Peter said.
Therefore, our focus area is to ensure that people with diabetes receive the right care and support to live a good life with diabetes, Peter added.
A Rajan Kumar, Managing Director of Novo Nordisk, said: “Our ultimate aim is to ensure that more people can live a life with diabetes free of complications.”
Dr. Mohammad Saiful, Head of Marketing of Novo Nordisk, said: “Our changing diabetes activities will help patients to achieve their control and also help the country to achieve sustainable development goals.”
About Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. Headquartered in Denmark, Novo Nordisk employs approximately 40,300 people in 75 countries and markets its products in more than 180 countries.